BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16784015)

  • 1. Anaphylactic reaction to drugs commonly used for gastrointestinal system diseases: 3 case reports and review of the literature.
    Demirkan K; Bozkurt B; Karakaya G; Kalyoncu AF
    J Investig Allergol Clin Immunol; 2006; 16(3):203-9. PubMed ID: 16784015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
    van Zyl J; van Rensburg C; Vieweg W; Fischer R
    Digestion; 2004; 70(1):61-9. PubMed ID: 15297779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T; Lemaire M; Agostini H
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nine cases of omeprazole allergy: cross-reactivity between proton pump inhibitors.
    Lobera T; Navarro B; Del Pozo MD; González I; Blasco A; Escudero R; Venturini M; Alarcón E
    J Investig Allergol Clin Immunol; 2009; 19(1):57-60. PubMed ID: 19274931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Pantoprazole Anaphylaxis with Cross Reactivity to All Proton Pump Inhibitors: Finding a Safe Alternative.
    Turedi O; Sozener ZC; Kendirlinan R; Bavbek S
    Curr Drug Saf; 2017; 12(3):198-200. PubMed ID: 28699491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe ranitidine-induced anaphylaxis: a case report and literature review.
    Aouam K; Bouida W; Ben Fredj N; Chaabane A; Boubaker H; Boukef R; Boughattas NA; Nouira S
    J Clin Pharm Ther; 2012 Aug; 37(4):494-6. PubMed ID: 22059646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer.
    Lazzaroni M; Bargiggia S; Bianchi Porro G
    Am J Gastroenterol; 1997 Apr; 92(4):649-52. PubMed ID: 9128316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaphylaxis to proton pump inhibitors.
    González P; Soriano V; López P; Niveiro E
    Allergol Immunopathol (Madr); 2002; 30(6):342-3. PubMed ID: 12464168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranitidine-induced anaphylaxis: clinical features, cross-reactivity, and skin testing.
    Park KH; Pai J; Song DG; Sim DW; Park HJ; Lee JH; Jeong KY; Pan CH; Shin I; Park JW
    Clin Exp Allergy; 2016 Apr; 46(4):631-9. PubMed ID: 26764898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
    Bardou M
    Rev Prat; 2001 Apr; 51(7):789-95. PubMed ID: 11387678
    [No Abstract]   [Full Text] [Related]  

  • 15. Pantoprazole versus ranitidine in the treatment of duodenal ulcer: a multicenter study in Brazil.
    Meneghelli UG; Zaterka S; de Paula Castro L; Malafaia O; Lyra LG
    Am J Gastroenterol; 2000 Jan; 95(1):62-6. PubMed ID: 10638560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaphylactic reactions to proton-pump inhibitors.
    Natsch S; Vinks MH; Voogt AK; Mees EB; Meyboom RH
    Ann Pharmacother; 2000 Apr; 34(4):474-6. PubMed ID: 10772433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid pump inhibitors. The treatment of gastroesophageal reflux.
    Hetzel D
    Aust Fam Physician; 1998 Jun; 27(6):487-91. PubMed ID: 9648315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.
    Miner P; Katz PO; Chen Y; Sostek M
    Am J Gastroenterol; 2003 Dec; 98(12):2616-20. PubMed ID: 14687806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhinitis and asthma due to ranitidine.
    Martínez AJ; Callejo Melgosa A; Fuentes GM; Martín García C
    J Investig Allergol Clin Immunol; 2006; 16(2):142-3. PubMed ID: 16689191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
    Farley A; Wruble LD; Humphries TJ
    Am J Gastroenterol; 2000 Aug; 95(8):1894-9. PubMed ID: 10950032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.